Filter
200
Text search:
PrEP
Featured
Recommendations
13
New Publications
32
Language
Document type
No document type
87
Guidelines
42
Studies & Reports
41
Strategic & Response Plan
15
Manuals
4
Infographics
3
Fact sheets
3
Training Material
2
Brochures
1
Situation Updates
1
Resource Platforms
1
Countries / Regions
South Africa
5
Global
5
Latin America and the Carribbean
4
Asia
4
Malawi
3
South–East Asia Region
3
Western and Central Europe
3
Eastern Europe
3
Russia
3
Georgia
3
Sierra Leone
2
Congo, Democratic Republic of
2
Ghana
2
Uganda
2
Haiti
2
Nepal
2
Zambia
2
Kenya
2
Argentina
2
Namibia
2
East and Southern Africa
2
Liberia
1
Nigeria
1
Senegal
1
Cameroon
1
Philippines
1
India
1
Germany
1
Syria
1
Cambodia
1
Rwanda
1
Brazil
1
Honduras
1
Lesotho
1
Western Pacific Region
1
Africa
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
41
Clinical Guidelines
16
Women & Child Health
4
Key Resources
3
Public Health
2
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
HIV
119
COVID-19
12
Planetary Health
6
NTDs
6
Rapid Response
4
Refugee
3
Polio
2
Mental Health
2
TB
2
Specific Hazards
2
Health Financing Toolbox
2
Cholera
1
Natural Hazards
1
Caregiver
1
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me
...
Evidence shows that oral pre-exposure prophylaxis (PrEP) reduces the risk of contracting HIV during sexual intercourse by more than 90% when taken daily. It is for this reason the National HIV Prevention Strategy 2015-2020 (2018 Revision) emphasi
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely
...
This technical brief aims to support these trends, accelerated by the COVID-19 pandemic, and improve PrEP uptake, persistence, and effective use by providing implementation guidance for differentiated and simplified service delivery. The brief aims
...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP
...
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public h
...
Rabies is a fatal viral disease, but is preventable in humans. The rabies virus is transmitted to humans through virus-laden saliva from a rabid animal, mostly dogs. The virus is shed in the saliva of an infected animal and can be introduced into another body through bites, scratches and any other
...
In 2024, we need US$1.5 billion to provide live-saving health care to millions of people in emergencies. An alarming combination of conflict, climate-related threats and increasing economic hardship mean an estimated 166 million people require health assistance.
The uneven distribution of HIV risks and burdens across populations is a well-substantiated fact, though seldom publicly acknowledged. Gay men and other men who have sex with men, people who inject drugs, sex workers, and transgender women are 24, 24, 13.5, and 49 times more likely to acquire HIV,
...
